<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="76210">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02113475</url>
  </required_header>
  <id_info>
    <org_study_id>PC14-1213-001</org_study_id>
    <nct_id>NCT02113475</nct_id>
  </id_info>
  <brief_title>Venous Thrombectomy/Thrombolysis Outcome Registry</brief_title>
  <acronym>VETTOR</acronym>
  <official_title>A Patient Outcome Study After Pharmacomechanical Catheter-directed Thrombolysis and Standard Treatment for Venous Thrombosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heart and Vascular Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heart and Vascular Outcomes Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deep Venous Thrombosis affects more than 350,000 individuals each year in the U.S.The
      Registry will track patient outcome and quality of life over 60 months for treatment with
      anticoagulation and elastic compression stockings and catheter-directed thrombolysis (CDT)
      in accordance with current treatment guidelines .
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life,</measure>
    <time_frame>60 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of Post-Thrombotic Syndrome</measure>
    <time_frame>60 Months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1800</enrollment>
  <condition>Deep Venous Thrombosis</condition>
  <condition>Post Thrombotic Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Participating study centers will enroll patients and enter data in the web-based registry
        that include demographics, clinical features,
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢Data obtained in line with good clinical practice, applicable laws and regulation

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Uchenna N Onyeachom</last_name>
    <role>Study Director</role>
    <affiliation>Heart and Vascular Outcomes Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Uchenna N Onyeachom</last_name>
    <phone>978-927-7800</phone>
    <email>uonyeachom@hvori.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Heart &amp; Vascular Outcomes Research Institute</name>
      <address>
        <city>Beverly</city>
        <state>Massachusetts</state>
        <zip>01915</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.venouspatientregistry.org</url>
  </link>
  <verification_date>March 2015</verification_date>
  <lastchanged_date>March 18, 2015</lastchanged_date>
  <firstreceived_date>April 9, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CDT</keyword>
  <keyword>PCDT</keyword>
  <keyword>DVT</keyword>
  <keyword>PTS</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
    <mesh_term>Postthrombotic Syndrome</mesh_term>
    <mesh_term>Postphlebitic Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
